Neogen Corporation (NEOG), a food safety solutions provider, Monday announced that it has agreed to sell its genomics business to Zoetis Inc., an animal health company, for $160 million.
The transaction is expected to close by the end of the first half of the firm's 2027 fiscal year.
As per the company, this is a planned divestiture to simplify the business and focus on core strategic markets.
The net proceeds from this deal are expected to be used primarily for debt reduction.
The Genomics business generated approximately $90 million in sales during fiscal year 2025, the food safety firm said in a statement.
In pre-market activity, NEOG shares were trading at $11.20, down 0.27% on the Nasdaq.
For comments and feedback contact: editorial@rttnews.com
Business News
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.